American Capital Advisory’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
American Capital Advisory's NVS Position: Q2 2026 in Review
American Capital Advisory reduced its Novartis (NVS) stake by 22% in Q2 2026, selling an estimated $3.15K and leaving 75 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #342.
American Capital Advisory first reported a position in NVS in Q1 2024 and has held it in 5 quarters since. The position peaked at $14.7K in Q1 2026. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- American Capital Advisory held 75 shares of Novartis worth $11.8K as of Q2 2026.
- American Capital Advisory sold 21 Novartis shares in Q2 2026, an estimated $3.15K.
- Novartis made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #342 holding.
- American Capital Advisory first reported a position in Novartis in Q1 2024 and has held it in 5 quarters since.
- American Capital Advisory's Novartis position peaked at $14.7K in Q1 2026.
- 1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.